Indinavir did not increase the short-term risk of adverse cardiovascular events relative to nucleoside reverse transcriptase inhibitor therapy in four phase III clinical trials
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Paul M. Coplan |
| Publication date | August 1, 2001 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |